44
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Social cognition and occupational reintegration in primary central nervous system lymphoma long-term survivors: a secondary analysis of a combined data set

, PhDORCID Icon, , MD, , , MD & , PhD

References

  • Pels H, Schmidt-Wolf IGH, Glasmacher A, et al. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol. 2003;21(24):4489–4495. doi:10.1200/JCO.2003.04.056
  • Bromberg JEC, Issa S, Bakunina K, et al. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): A randomised, open-label, phase 3 intergroup study. Lancet Oncol. 2019;20(2):216–228. doi:10.1016/S1470-2045(18)30747-2
  • Illerhaus G, Kasenda B, Ihorst G, et al. High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: A prospective, single-arm, phase 2 trial. Lancet Haematol. 2016;3(8):e388–e397. doi:10.1016/S2352-3026(16)30050-3
  • Seidel S, Pels H, Schlömer S, et al. Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma. Neurology. 2020;95(23):e3138–e3144. doi:10.1212/WNL.0000000000010949
  • Wiemann G, Pertz M, Kowalski T, Seidel S, Schlegel U, Thoma P. Complete response to therapy: Why do primary central nervous system lymphoma patients not return to work? J Neurooncol. 2020;149(1):171–179. doi:10.1007/s11060-020-03587-5
  • Pertz M, Kowalski T, Thoma P, Schlegel U. What is on your mind? Impaired social cognition in primary central nervous system lymphoma patients despite ongoing complete remission. Cancers (Basel). 2021;13(5):943. doi:10.3390/cancers13050943
  • Westerhof-Evers HJ, Fasotti L, van der Naalt J, Spikman JM. Participation after traumatic brain injury: The surplus value of social cognition tests beyond measures for executive functioning and dysexecutive behavior in a statistical prediction model. Brain Inj. 2019;33(1):78–86. doi:10.1080/02699052.2018.1531303
  • Adolphs R. The neurobiology of social cognition. Curr Opin Neurobiol. 2001;11(2):231–239. doi:10.1016/S0959-4388(00)00202-6
  • Frith CD. Social cognition. Philos Trans R Soc Lond B Biol Sci. 2008;363(1499):2033–2039. doi:10.1098/rstb.2008.0005
  • Arioli M, Crespi C, Canessa N. Social cognition through the lens of cognitive and clinical neuroscience. Biomed Res Int. 2018;2018:4283427–4283418. doi:10.1155/2018/4283427
  • Channon S, Crawford S. Mentalising and social problem-solving after brain injury. Neuropsychol Rehabil. 2010;20(5):739–759. doi:10.1080/09602011003794583
  • Decety J. The neuroevolution of empathy. Ann N Y Acad Sci. 2011;1231(1):35–45. doi:10.1111/j.1749-6632.2011.06027.x
  • Shamay-Tsoory SG, Aharon-Peretz J, Perry D. Two systems for empathy: A double dissociation between emotional and cognitive empathy in inferior frontal gyrus versus ventromedial prefrontal lesions. Brain. 2009;132(Pt 3):617–627. doi:10.1093/brain/awn279
  • Shamay-Tsoory SG, Aharon-Peretz J. Dissociable prefrontal networks for cognitive and affective theory of mind: A lesion study. Neuropsychologia. 2007;45(13):3054–3067. doi:10.1016/j.neuropsychologia.2007.05.021
  • Cotter J, Granger K, Backx R, Hobbs M, Looi CY, Barnett JH. Social cognitive dysfunction as a clinical marker: A systematic review of meta-analyses across 30 clinical conditions. Neurosci Biobehav Rev. 2018;84:92–99. doi:10.1016/j.neubiorev.2017.11.014
  • McDonald S. Impairments in social cognition following severe traumatic brain injury. J Int Neuropsychol Soc. 2013;19(3):231–246. doi:10.1017/S1355617712001506
  • Njomboro P. Social cognition deficits: Current position and future directions for neuropsychological interventions in cerebrovascular disease. Behav Neurol. 2017;2017:2627487–2627411. doi:10.1155/2017/2627487
  • Struchen M, Clark A, Sander A, Mills MR, Evans G, Kurtz DM. Relation of executive functioning and social communication measures to functional outcomes following traumatic brain injury. NeuroRehabilitation. 2008;23:185–198. www.semanticscholar.org/paper/Relation-of-executive-functioning-and-social-to-Struchen-Clark/2a703ee7cd147a5f24eafe14a01fd265328366e7.
  • Paulus C. Der Saarbrücker Persönlichkeitsfragebogen SPF(IRI) zur Messung von Empathie. Psychometrische Evaluation Der Deutschen Version Des Interpersonal Reactivity Index. 2009.
  • Davis MH. Measuring individual differences in empathy: Evidence for a multidimensional approach. J Personality Soc Psychol. 1983;44(1):113–126. doi:10.1037/0022-3514.44.1.113
  • Bach M, Bach D, Zwaan M, Serim M. Validierung der deutschen Version der 20-Item Toronto-Alexithymie-Skala bei Normalpersonen und psychiatrischen Patienten. Undefined. 1996. www.semanticscholar.org/paper/Validierung-der-deutschen-Version-der-20-Item-bei-Bach-Bach/799ce7ce89498542aa961f861faa433a9a6df2a9.
  • Taylor GJ, Ryan D, Bagby M. Toward the development of a new self-report alexithymia scale. Psychother Psychosom. 1985;44(4):191–199. doi:10.1159/000287912
  • Dziobek I, Rogers K, Fleck S, et al. Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). J Autism Dev Disord. 2008;38(3):464–473. doi:10.1007/s10803-007-0486-x
  • Thoma P, Schmidt T, Juckel G, Norra C, Suchan B. Nice or effective? Social problem solving strategies in patients with major depressive disorder. Psychiatry Res. 2015;228(3):835–842. doi:10.1016/j.psychres.2015.05.015
  • Fliessbach K, Rogowski S, Hoppe C, et al. Computer-based assessment of cognitive functions in brain tumor patients. J Neurooncol. 2010;100(3):427–437. doi:10.1007/s11060-010-0194-9
  • Fliessbach K, Hoppe C, Schlegel U, Elger C, Helmstaedter C. NeuroCogFX - eine computergestützte neuropsychologische Testbatterie für Verlaufsuntersuchungen bei neurologischen Erkrankungen. Fortschr Neurol Psychiatr. 2006;74(11):643–650. doi:10.1055/s-2006-932162
  • Flechl B, Ackerl M, Sax C, et al. Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. J Neurooncol. 2012;109(2):331–339. doi:10.1007/s11060-012-0897-1
  • Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi:10.1093/jnci/85.5.365
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
  • Kühner C, Bürger C, Keller F, Hautzinger M. Reliabilität und Validität des revidierten Beck-Depressionsinventars (BDI-II). Nervenarzt. 2007;78(6):651–656. doi:10.1007/s00115-006-2098-7
  • Liaset IF, Kvam L. Experiences of returning to work after brain tumor treatment. Work. 2018;60(4):603–612. doi:10.3233/WOR-182768
  • Rusbridge SL, Walmsley NC, Griffiths SB, Wilford PA, Rees JH. Predicting outcomes of vocational rehabilitation in patients with brain tumours. Psychooncology. 2013;22(8):1907–1911. doi:10.1002/pon.3241
  • Leeper HE, Vera E, Christ A, et al. Association of employment status with symptom burden and health-related quality of life in people living with primary CNS tumors. Neurology. 2023;100(16):e1723–e1736. doi:10.1212/WNL.0000000000207082
  • Feuerstein M, Hansen JA, Calvio LC, Johnson L, Ronquillo JG. Work productivity in brain tumor survivors. J Occup Environ Med. 2007;49(7):803–811. doi:10.1097/JOM.0b013e318095a458
  • Maguire R, Hanly P, Maguire P. Living well with chronic illness: How social support, loneliness and psychological appraisals relate to well-being in a population-based European sample. J Health Psychol. 2021;26(10):1494–1507. doi:10.1177/1359105319883923
  • Batchelor TT. Primary central nervous system lymphoma: A curable disease. Hematol Oncol. 2019;37 Suppl 1(S1):15–18. doi:10.1002/hon.2598
  • Doolittle ND, Korfel A, Lubow MA, et al. Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma. Neurology. 2013;81(1):84–92. doi:10.1212/WNL.0b013e318297eeba
  • Juergens A, Pels H, Rogowski S, et al. Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Ann Neurol. 2010;67(2):182–189. doi:10.1002/ana.21824

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.